Home » Newsletters » BioWorld Asia

BioWorld Asia

May 24, 2000

View Archived Issues

CeNeS Buying Cambridge Neuro In All-Stock Deal Valued At $44M

Antisoma Stock Takes Hit Following Independent Study

Study Of Rare Disorder Provides Clues For New Cancer Therapies

French Researchers Say There Are Only About 30,000 Genes

Oxford GlycoSciences Issued Broad Patent On Proteomics

NicOx Reports Early Phase II Results, Starts Phase I Study

Watson, Arntzen Among Those Adding Input To Israeli Biotech

SkyePharma Changes Strategy, Plans More Development Work

ExonHit, Collaborators Identify Markers Linked To Hypoxia

Queensland Group Develops Genetic Test For Skin Cancer

United Nations Takes Step Toward Labeling GM Food

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...